Human Molecular Genetics Advance Access published online on March 16, 2005
Human Molecular Genetics, doi:10.1093/hmg/ddi121
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory of Genetics and Molecular Medicine, Department of Genomics and Proteomics, Instituto de Biomedicina, CSIC, Valencia, Spain
* To whom correspondence should be addressed. Mutations in GDAP1, the ganglioside-induced differentiation-associated protein 1 gene, cause Charcot-Marie-Tooth (CMT) type 4A, a severe autosomal recessive form of neuropathy associated with either demyelinating or axonal phenotypes. Here we demonstrate that GDAP1 has far greater expression in neurons than in myelinating Schwann cells. We investigated cell localization of GDAP1 by means of transient overexpression and co-localization with organelle markers in COS-7 cells, and by Western blot analysis of subcell fractions with anti-GDAP1 polyclonal antibodies in a human neuroblastoma cell line. We observed that GDAP1 is localized in mitochondria. We also show that C-terminal transmembrane domains are necessary for the correct localization in mitochondria; however, missense mutations do not change the mitochondrial pattern of the wild-type protein. Our findings suggest that CMT4A disease is in fact a mitochondrial neuropathy mainly involving axons, and represents a disease belonging to the new category of mitochondrial disorders caused by mutations in nuclear genes. We postulate that GDAP1 may be related with the maintenance of the mitochondrial network.
Article
GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria
2 Department of Neurology and Centre for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, USA
Francesc Palau, E-mail: fpalau{at}ibv.csic.es
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M M Reilly and M E Shy Diagnosis and new treatments in genetic neuropathies J. Neurol. Neurosurg. Psychiatry, December 1, 2009; 80(12): 1304 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lupo, M. I. Galindo, D. Martinez-Rubio, T. Sevilla, J. J. Vilchez, F. Palau, and C. Espinos Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type 4C affect its localization in the plasma membrane and endocytic pathway Hum. Mol. Genet., December 1, 2009; 18(23): 4603 - 4614. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liesa, M. Palacin, and A. Zorzano Mitochondrial Dynamics in Mammalian Health and Disease Physiol Rev, July 1, 2009; 89(3): 799 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sevilla, T. Jaijo, D. Nauffal, D. Collado, M. J. Chumillas, J. J. Vilchez, N. Muelas, L. Bataller, R. Domenech, C. Espinos, et al. Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy Brain, November 1, 2008; 131(11): 3051 - 3061. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-F. Suen, K. L. Norris, and R. J. Youle Mitochondrial dynamics and apoptosis Genes & Dev., June 15, 2008; 22(12): 1577 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Davies, K. A. Powell, K. E. White, W. Yip, V. Hogan, A. J. Hollins, J. R. Davies, M. Piechota, D. G. Brownstein, S. J. Moat, et al. A missense mutation in the murine Opa3 gene models human Costeff syndrome Brain, February 1, 2008; 131(2): 368 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Niemann, M. Ruegg, V. La Padula, A. Schenone, and U. Suter Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease J. Cell Biol., September 26, 2005; 170(7): 1067 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bolis, S. Coviello, S. Bussini, G. Dina, C. Pardini, S. C. Previtali, M. Malaguti, P. Morana, U. Del Carro, M. L. Feltri, et al. Loss of Mtmr2 Phosphatase in Schwann Cells But Not in Motor Neurons Causes Charcot-Marie-Tooth Type 4B1 Neuropathy with Myelin Outfoldings J. Neurosci., September 14, 2005; 25(37): 8567 - 8577. [Abstract] [Full Text] [PDF] |
||||






